Analysed NEUROGENE INC (NGNE:NASDAQ) News Sources
Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates
24-03-2026
yahoo.com
Neurogene CEO Details NGN-401 Rett Trial, FDA Alignment, and Key 2026 Catalysts at Conference
21-03-2026
marketbeat.com
Here Are Friday’s Top Wall Street Analyst Research Calls: Block, Costco, Dollar Tree, Duolingo, Palantir Technologies, Southwest Airlines, Synopsis, Warner Bros. Discovery, and More
27-02-2026
247wallst.com
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
26-02-2026
yahoo.com
Neurogene Maps NGN-401 Pivotal Rett Timeline, Mid-2026 Data Update at Guggenheim Summit
14-02-2026
marketbeat.com
What is the current price of NEUROGENE INC (NGNE:NASDAQ)?
The current price of NEUROGENE INC (NGNE:NASDAQ) is $20.39.
NEUROGENE INC (NGNE:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is $-0.98.
NEUROGENE INC (NGNE:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is -4.5859%.
What is the most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ)?
The most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for NEUROGENE INC (NGNE:NASDAQ)?
The most recent sentiment for NEUROGENE INC (NGNE:NASDAQ) is .
SEC-8K** Filing Available For NEUROGENE INC (NGNE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.